Another good SGLT2I study. Overall hospitalization reduction! Interaction by uAlbumin interesting. Do the HFpEF trials have data on uAlbumin? I think that SGLT2I treat comorbidities (which are key in HFpEF) and selecting who benefits most would be great.
@mvaduganathan @HFpEF